Table of contents:
Latest news & events
Featured presentation
In our own words
IR HOME
News & Events
Press releases
Events
Presentations
Financials
SEC filings
Analyst coverage
Stock info
Quote & chart
History & investment calculator
Governance
Management
Board of directors
Governance documents
Committee composition
Resources
Investor contact
Online investor kit
FAQs
RSS feeds
MENU
Investor Relations
Latest
September 25, 2021
New Study Highlights the Value of Genetic Testing to Guide Clinical Management and Improve Outcomes for Epilepsy Patients
READ MORE
NYSE: NVTA
27.50
-
0.23
-
0.83%
Volume:
1,377,956
20 minute delay
October 15, 2021
IR HOME
News & Events
Press releases
Events
Presentations
Financials
SEC filings
Analyst coverage
Stock info
Quote & chart
History & investment calculator
Governance
Management
Board of directors
Governance documents
Committee composition
Resources
Investor contact
Online investor kit
FAQs
RSS feeds
INVITAE HOME
Latest
September 25, 2021
New Study Highlights the Value of Genetic Testing to Guide Clinical Management and Improve Outcomes for Epilepsy Patients
READ MORE
NYSE: NVTA
27.50
-
0.23
-
0.83%
Volume:
1,377,956
20m delay
October 15, 2021
Latest news & events
Feature presentation
Events
In our own words
Thumb
Download
Invitae’s mission
What sets us apart
How we’ll do it
Impact on patients
Investor Toolkit
Email Alerts
Sign up to receive Invitae financial information by email.
Email Address:
*
I'D LIKE TO RECEIVE EMAILS ABOUT:
*
Press Release
SEC Filing
Presentation
Event
End of Day Stock Quote
Enter the code shown above.
Investor Contact
1400 16th St.
San Francisco, CA, 94103
Email:
ir@invitae.com
Privacy
|
Terms
|
Licensing
|
Contact
© Invitae Corporation. All rights reserved.
Powered By Q4 Inc.
5.56.0.1